Koch Thomas Von - Net Worth and Insider Trading

Koch Thomas Von Net Worth

The estimated net worth of Koch Thomas Von is at least $12 Million dollars as of 2024-05-24. Koch Thomas Von is the 10% Owner of DiaMedica Therapeutics Inc and owns about 4,326,435 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $12 Million. Details can be seen in Koch Thomas Von's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Koch Thomas Von has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).

Transaction Summary of Koch Thomas Von

To

Koch Thomas Von Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Koch Thomas Von owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .

Click here to see the complete history of Koch Thomas Von’s form 4 insider trades.

Insider Ownership Summary of Koch Thomas Von

Ticker Comapny Transaction Date Type of Owner
DMAC DiaMedica Therapeutics Inc 2023-06-23 10 percent owner

Koch Thomas Von Latest Holdings Summary

Koch Thomas Von currently owns a total of 1 stock. Koch Thomas Von owns 4,326,435 shares of DiaMedica Therapeutics Inc (DMAC) as of June 23, 2023, with a value of $12 Million.

Latest Holdings of Koch Thomas Von

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DMAC DiaMedica Therapeutics Inc 2023-06-23 4,326,435 2.85 12,330,340

Holding Weightings of Koch Thomas Von


Koch Thomas Von Form 4 Trading Tracker

According to the SEC Form 4 filings, Koch Thomas Von has made a total of 4 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 1,470,588 shares on June 23, 2023, which cost Koch Thomas Von around $5 Million.

Insider Trading History of Koch Thomas Von

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Koch Thomas Von Trading Performance

GuruFocus tracks the stock performance after each of Koch Thomas Von's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Koch Thomas Von is -5.17%. GuruFocus also compares Koch Thomas Von's trading performance to market benchmark return within the same time period. The performance of stocks bought by Koch Thomas Von within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Koch Thomas Von's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Koch Thomas Von

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.85
Relative Return to S&P 500(%) 6.25

Koch Thomas Von Ownership Network

Ownership Network List of Koch Thomas Von

No Data

Ownership Network Relation of Koch Thomas Von


Koch Thomas Von Owned Company Details

What does DiaMedica Therapeutics Inc do?

Who are the key executives at DiaMedica Therapeutics Inc?

Koch Thomas Von is the 10 percent owner of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , director & President and CEO Dietrich John Pauls , and 10 percent owner Ab Tomenterprise .

DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary

Over the past 18 months, Koch Thomas Von made 3 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 1,470,588. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 527,114 shares made by David J. Wambeke , and a net purchase of 73,363 shares made by Richard D. Pilnik .

In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.

DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

DiaMedica Therapeutics Inc Insider Transactions

No Available Data

Koch Thomas Von Mailing Address

Above is the net worth, insider trading, and ownership report for Koch Thomas Von. You might contact Koch Thomas Von via mailing address: Tomenterprise Ab, Box 5322, Stockholm V7 102 47.

Discussions on Koch Thomas Von

No discussions yet.